Hybridoma App Note – Restoring high-titer antibody production

app note restoring high titer antibody production 202508

Scientists at a biotechnology company observed antibody titers decreasing over time in a commercial hybridoma line, rendering the cell line unsuitable for continued use. Time-course imaging and immunofluorescent reporting of antibody secretion revealed that only 0.3% of the hybridoma population was secreting detectable antibody. Using CellRaft Technology, antibody titer was recovered to levels that qualified […]